In Durham, Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Vilazodone to its oral tablets portfolio. The drug is therapeutically equivalent to Allergan’s VIIBRYD and approved to treat major depressive disorder in adults. Accord’s product, offered in 10 mg, 20 mg, and 40 mg tablets, is currently available to ship. Depression is a leading cause of disability worldwide.